Biblio Discovery — Demo Discovery Service

266 hasil

Menampilkan 1–20 · 0,34 detik · RSS

Jurnal

Journal of Cancer Research and Practice

ISSN 2311-3006 · Wolters Kluwer Medknow Publications · 266 artikel di indeks

  1. Artikel Jurnal

    Immune-related Myocarditis, Guillain–Barré Syndrome, and Myasthenia Gravis Exacerbation after Pembrolizumab Therapy in a Patient with Recurrent B3 Thymoma: A Case Report

    Yuan-Jui Yu; Hsueh-Wen Hsueh; Chih-Ning Chen dkk.

    Journal of Cancer Research and Practice, Vol. 13 No. 2 · 2026 · Inggris · DOAJ

    Thymic epithelial tumors, including thymoma and thymic carcinoma, are rare malignancies for which platinum-based chemotherapy is the standard first-line treatment. Second-line options include chemotherapy, targeted therapy, immune checkpoint inhibitors (ICIs), or combination regimens. While thymoma…

  2. Artikel Jurnal

    Alpha-Fetoprotein-producing Neuroendocrine Carcinoma of the Pancreas with Multiple Liver Metastasis: A Case Report

    Jhih-Sheng Wang; Tse-Ching Chen; Kun-Yun Yeh dkk.

    Journal of Cancer Research and Practice, Vol. 13 No. 2 · 2026 · Inggris · DOAJ

    Alpha-fetoprotein (AFP) is a well-known tumor marker for hepatocellular carcinoma (HCC). However, Grade 3 AFP-producing neuroendocrine tumor (NET) is a rare and aggressive cancer. We report the case of a 68-year-old female admitted for multiple liver tumors and an elevated AFP level discovered…

  3. Artikel Jurnal

    Impact of Early versus Delayed G-CSF Administration on Clinical Outcomes in Chemotherapy-induced Neutropenia: A Propensity Score-matching Cohort Study

    Hsieh-Ting Lin; Lun-Wei Chiou; Nei-Min Chu dkk.

    Journal of Cancer Research and Practice, Vol. 13 No. 2 · 2026 · Inggris · DOAJ

    Background: Chemotherapy-induced neutropenia is a significant complication in cancer treatment, increasing the risk of infection and treatment delay. Granulocyte-colony stimulating factor (G-CSF) is used to treat and prevent neutropenia; however, the optimal timing of administration remains…

  4. Artikel Jurnal

    Combination Therapy of Anti-PD-1 Immunotherapy and Taxanes in Relapsed and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Real-world Single-center Retrospective Study

    Ting-Wen Liu; Nai-Wen Su; Yi-Fang Chang

    Journal of Cancer Research and Practice, Vol. 13 No. 2 · 2026 · Inggris · DOAJ

    Background: Recurrent/metastatic head and neck squamous cell carcinoma (R/M-HNSCC) carries a poor prognosis despite the current standard of care. This study aimed to investigate the efficacy and safety of a novel non-cisplatin-containing chemo-immunotherapy regimen combining a programmed cell death…

  5. Artikel Jurnal

    A Systematic Review of Interventions for Pain in Patients with Incurable Pancreatic Cancer

    Emily G. Seymour-Jackson; Chloe Thomson; Chloe J. Kiely dkk.

    Journal of Cancer Research and Practice, Vol. 13 No. 2 · 2026 · Inggris · DOAJ

    Objective: Incurable pancreatic cancer poses challenging analgesic requirements, which subsequently affect the quality of life of patients. The aim of this review was to assess the available methods of managing pain in incurable pancreatic cancer, how these are utilized, and their effectiveness in…

  6. Artikel Jurnal

    From Crisis to Cure: A Case Report of Pathologic Complete Response in a Young Male with BRAF-mutant dMMR Metastatic Colorectal Cancer after Immunotherapy

    Jen-Yu Chuang; Johnson Lin; Nai-Wen Su

    Journal of Cancer Research and Practice, Vol. 13 No. 2 · 2026 · Inggris · DOAJ

    Metastatic colorectal cancer (mCRC) with a BRAFV600E mutation is an aggressive subtype with poor prognosis and limited response to standard chemotherapy. However, coexisting deficient mismatch repair (dMMR) is associated with improve outcomes with immunotherapy. We present the case of early-onset…

  7. Artikel Jurnal

    Tumor Lysis Syndrome in a Super-responder to Chemoimmunotherapy for Nasopharyngeal Carcinoma: A Case Report

    Kuan-Yu Chen; Li-Chun Lu

    Journal of Cancer Research and Practice, Vol. 13 No. 2 · 2026 · Inggris · DOAJ

    We present the case of a 54-year-old male with nasopharyngeal cancer accompanied by huge liver metastasis, an extremely high Epstein–Barr virus viral load, and B symptoms. Despite aggressive hydration and close laboratory monitoring, he developed tumor lysis syndrome (TLS) and acute kidney injury…

  8. Artikel Jurnal

    Acquired Resistance in BRAF V600E-Mutant MSS Colorectal Cancer: Two Cases Highlighting Molecular Adaptation and Salvage Strategies

    Wen-Ying Lin; Ming-Huang Chen

    Journal of Cancer Research and Practice, Vol. 13 No. 1 · 2026 · Inggris · DOAJ

    BRAF V600E mutations in metastatic colorectal cancer (mCRCs) are associated with aggressive tumor behavior and poor prognosis, with limited benefit from BRAF inhibitors due to rapid resistance mechanisms. Here, we report the two cases of microsatellite-stable, BRAF V600E-mutated mCRC demonstrating…

  9. Artikel Jurnal

    Treatment Outcomes in Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer Patients with and without Progression after Completion of Reimbursed Cyclin-dependent Kinase 4/6 Inhibitors in Taiwan: A Single-institution Experience

    Yi-Hsuan Hsu; Po-Shen Yang; Yuan-Ching Chang dkk.

    Journal of Cancer Research and Practice, Vol. 13 No. 1 · 2026 · Inggris · DOAJ

    Background: Combining cyclin-dependent kinase 4/6 inhibitors (CDK4/6is) with endocrine therapy is the standard first-line treatment for metastatic hormone receptor (HR)-positive, HER2-negative breast cancer. In Taiwan, it is estimated that nearly half of the patients completing 2 years of CDK4/6i…

  10. Artikel Jurnal

    Unusual Presentation of Secondary Chronic Myeloid Leukemia in a Metastatic Breast Cancer Patient Receiving Cyclin-dependent Kinase 4/6 Inhibitor Therapy: A Case Report

    Chia-Hung Wu; Jing-Lan Liu; Wen-Yung Tsai dkk.

    Journal of Cancer Research and Practice, Vol. 13 No. 1 · 2026 · Inggris · DOAJ

    An association between breast cancer treatment and secondary chronic myeloid leukemia (CML) has rarely been reported. In this report, we present a 62-year-old postmenopausal woman initially diagnosed with hormone receptor (HR)-positive, HER2-negative metastatic breast cancer who subsequently…

  11. Artikel Jurnal

    Does Genetic Testing Influence Outcomes: Early Experience in Melanoma Case Series

    Ryan Reyes; George Skenteris; Stella Self dkk.

    Journal of Cancer Research and Practice, Vol. 13 No. 1 · 2026 · Inggris · DOAJ

    Background: The treatment and prognosis of melanoma have historically been based on histologic stage and Breslow depth; however, due to the increase in surveillance, melanomas are being identified at an earlier stage and lower Breslow depth. Advances in genetic testing, such as Decision Dx®, mean…

  12. Artikel Jurnal

    A Long-standing Perianal Fistula Hiding an Adenocarcinoma: A Case Report

    I-Wei Lin; Ying-Wen Su; Ching-Heng Ting dkk.

    Journal of Cancer Research and Practice, Vol. 13 No. 1 · 2026 · Inggris · DOAJ

    Fistula-associated anal adenocarcinoma (FAAC) is an uncommon disease. Due to the clinical similarity in the symptoms to benign anal fistulas, FAAC can confuse clinicians and lead to delayed diagnosis. We report a case of FAAC in a patient with a 20-year history of an unhealed perianal fistula and…

  13. Artikel Jurnal

    Pembrolizumab-induced Guillain–Barré Syndrome in Early-stage Triple-negative Metaplastic Breast Cancer Responded to Intravenous Immunoglobulin and Steroids: A Case Report

    Yu-Chen Chiu; Tom Wei-Wu Chen

    Journal of Cancer Research and Practice, Vol. 13 No. 1 · 2026 · Inggris · DOAJ

    Pembrolizumab is an immune checkpoint inhibitor that blocks the PD-1 pathway on T-cells. It has been associated with a variety of immune-related adverse events, including Guillain–Barré syndrome (GBS), a rare but critical event. We report the case of a patient with early-stage metaplastic breast…

  14. Artikel Jurnal

    Real-world Evidence of Treatment Outcomes in Mantle Cell Lymphoma: A Single-center Experience in Southern Taiwan

    Chien-Lin Lee; Chin-Yuan Kuo; Ming-Chun Ma dkk.

    Journal of Cancer Research and Practice, Vol. 13 No. 1 · 2026 · Inggris · DOAJ

    Background: Mantle cell lymphoma (MCL) is a rare and aggressive B-cell lymphoma often diagnosed at an advanced stage. Standard first-line treatment includes bendamustine-rituximab or cytarabine-based regimens, sometimes followed by autologous stem cell transplantation (autoSCT). The TRIANGLE trial…

  15. Artikel Jurnal

    Case Report of Primary Hepatoid Lung Carcinoma in a 45-year-old Woman

    Yu-Yang Hua; Shih-Yu Huang

    Journal of Cancer Research and Practice, Vol. 12 No. 3 · 2025 · Inggris · DOAJ

    A 45-year-old woman initially presented with back pain and was subsequently given a diagnosis of hepatoid adenocarcinoma (HAC) of the lung, stage IV, T3N0M1b. No actionable mutations were detected. A multidisciplinary therapeutic approach, including atezolizumab plus bevacizumab treatment…

  16. Artikel Jurnal

    Impact of COVID-19 on Timeliness of Receiving Systemic Therapy for Patients Diagnosed with Lung Cancer

    Mahesh Maiyani; Kris Wain; Nikki M. Carroll dkk.

    Journal of Cancer Research and Practice, Vol. 12 No. 3 · 2025 · Inggris · DOAJ

    Background: During the COVID-19 pandemic, patients newly diagnosed with lung cancer faced potential delays in accessing timely cancer treatment. Little information exists on how COVID-19 impacted the timeliness of receiving a first course of systemic therapy after a lung cancer diagnosis. Materials…

  17. Artikel Jurnal

    Evaluating the Impact of Primary Tumor Resection on EGFR-TKI-treated Patients with Advanced Lung Cancer: A Multicenter Propensity-matched Study

    Eva Yu-Hsuan Chuang; Chiao-En Wu; Tzu-Wei Kuo dkk.

    Journal of Cancer Research and Practice, Vol. 12 No. 2 · 2025 · Inggris · DOAJ

    Background: Nonsmall-cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations is exceptionally sensitive to EGFR tyrosine kinase inhibitors (TKIs). Despite this, disease progression commonly occurs at the primary site, prompting debate on the potential advantages of…

  18. Artikel Jurnal

    Pembrolizumab as an Unconventional First-line Salvage Therapy in Primary Mediastinal Large B-cell Lymphoma: A Case Report

    Szu-Chi Yao; Yu-Hsuan Kuo

    Journal of Cancer Research and Practice, Vol. 12 No. 3 · 2025 · Inggris · DOAJ

    Primary mediastinal large B-cell lymphoma (PMBCL) is a rare and aggressive subtype of non-Hodgkin lymphoma with unique clinical and molecular characteristics. We report the case of a young woman diagnosed with PMBCL who presented with a bulky mediastinal mass and responded favorably to…

  19. Artikel Jurnal

    Pancreatic Cancer Presenting with Thrombotic Thrombocytopenic Purpura: A Case Report and Review of Literature

    Yeh-Chin Wang; Yi-Chung Chan; Hsiu-Po Wang dkk.

    Journal of Cancer Research and Practice, Vol. 12 No. 2 · 2025 · Inggris · DOAJ

    Thrombotic thrombocytopenic purpura (TTP) is a rare form of thrombotic microangiopathy (TMA). Cancer-related TMA typically arises from microvascular metastasis and bone marrow involvement. ADAMTS13 is a plasma protease that regulates von Willebrand factor and prevents platelet aggregation and…

  20. Artikel Jurnal

    Ten-year Experience and Evolving of Palliative Care at a Tertiary Medical Center in Taiwan

    Hsu-Lin Lee; Po-Huang Chen; Jia-Hong Chen dkk.

    Journal of Cancer Research and Practice, Vol. 12 No. 3 · 2025 · Inggris · DOAJ

    Background: Palliative care (PC) improves quality of life for patients with life-threatening illnesses. Despite global efforts, PC access remains limited. This study evaluated the 10-year trends of PC coverage and its impact on survival among advanced cancer patients at a tertiary medical center in…